RDVault, an investee company within the Deepbridge Life Sciences EIS portfolio, has won Tech Nation's fourth Rising Stars competition, which recognises the best early-stage technology scale-ups across the UK.
Andrew Aldridge, Partner & Head of Marketing at Deepbridge, recently spoke with Professional Adviser to discuss the UK Government's current tagline of 'Building Back Better' which is focused on the realisation that we all can live in a smarter way and that the UK has the opportunity to be at the forefront of twenty-first century sus
Wastefront, which is behind plans to build a £100m tyre recycling plant at The Port of Sunderland, has revealed a partnership with one of Deepbridge's Technology Growth EIS Companies, ENSO Tyres Limited.
GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently won a £50,000 award that is to be given to Shannon Beattie (CEO - GenoME Diagnostics) as part of the celebrations marking International Women’s Day on March 8th 2022, which will be used to aid early detection of ovarian cancer.
One of Deepbridge Capital's Life Sciences Investment Managers, Ben Carter, recently spoke to IFA Magazine about the role of an investment manager and goes into more detail of the dealflow, networks and sector specific expertise of the Deepbridge Life Sciences EIS portfolio.
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Summary of the Deepbridge Explore Webinar
Simon Tutton, Regional Director (South West England and South Wales), Deepbridge Capital
